Yaghini Fariborz A, Li Fang, Malik Kafait U
Department of Pharmacology and Centers of Vascular Biology and Connective Tissue Diseases, College of Medicine, University of Tennessee Health Science Center, Memphis, Tennessee 38163, USA.
J Biol Chem. 2007 Jun 8;282(23):16878-90. doi: 10.1074/jbc.M610494200. Epub 2007 Apr 18.
Syk, a 72-kDa tyrosine kinase, is involved in development, differentiation, and signal transduction of hematopoietic and some non-hematopoietic cells. This study determined if Syk is expressed in vascular smooth muscle cells (VSMC) and contributes to angiotensin II (Ang II) signaling and protein synthesis. Syk was found in VSMC and was phosphorylated by Ang II through AT1 receptor. Ang II-induced Syk phosphorylation was inhibited by piceatannol and dominant negative but not wild type Syk mutant. Syk phosphorylation by Ang II was attenuated by cytosolic phospholipase A(2) (cPLA(2)) inhibitor pyrrolidine-1 and retrovirus carrying small interfering RNAs (shRNAs) of this enzyme. Arachidonic acid (AA) increased Syk phosphorylation, and AA- and Ang II-induced phosphorylation was diminished by inhibitors of AA metabolism (5,8,11,14-eicosatetraynoic acid) and lipoxygenase (LO; baicalein) but not cyclooxygenase (indomethacin). AA metabolites formed via LO, 5(S)-, 12(S)-, and 15(S)-hydroxyeicosatetraenoic acids, which activate p38 MAPK, increased Syk phosphorylation. p38 MAPK inhibitor SB202190, and dominant negative p38 MAPK mutant attenuated Ang II- and AA-induced Syk phosphorylation. Adenovirus dominant negative c-Src mutant abolished Ang II - and AA-induced Syk phosphorylation and SB202190, and dominant negative p38 MAPK mutant inhibited Ang II-induced c-Src phosphorylation. Syk dominant negative mutant but not epidermal growth factor receptor blocker AG1478 also inhibited Ang II-induced VSMC protein synthesis. These data suggest that Syk expressed in VSMC is activated by Ang II through p38 MAPK-activated c-Src subsequent to cytosolic phospholipase A(2) and generation of AA metabolites via LO, and it mediates Ang II-induced protein synthesis independent of epidermal growth factor receptor transactivation (Ang II --> cPLA(2) --> AA metabolites of LO --> p38 MAPK --> c-Src --> Syk --> protein synthesis).
Syk是一种72 kDa的酪氨酸激酶,参与造血细胞和一些非造血细胞的发育、分化及信号转导。本研究确定Syk是否在血管平滑肌细胞(VSMC)中表达,并参与血管紧张素II(Ang II)信号传导和蛋白质合成。研究发现VSMC中存在Syk,且Ang II通过AT1受体使其磷酸化。白皮杉醇和显性负性而非野生型Syk突变体可抑制Ang II诱导的Syk磷酸化。Ang II诱导的Syk磷酸化可被胞质磷脂酶A2(cPLA2)抑制剂吡咯烷-1和携带该酶小干扰RNA(shRNA)的逆转录病毒减弱。花生四烯酸(AA)可增加Syk磷酸化,AA和Ang II诱导的磷酸化可被AA代谢抑制剂(5,8,11,14-二十碳四烯酸)和脂氧合酶(LO;黄芩苷)而非环氧化酶(吲哚美辛)减弱。通过LO形成的AA代谢产物,5(S)-、12(S)-和15(S)-羟基二十碳四烯酸,可激活p38丝裂原活化蛋白激酶(MAPK),增加Syk磷酸化。p38 MAPK抑制剂SB202190和显性负性p38 MAPK突变体可减弱Ang II和AA诱导的Syk磷酸化。腺病毒显性负性c-Src突变体可消除Ang II和AA诱导的Syk磷酸化,SB202190和显性负性p38 MAPK突变体可抑制Ang II诱导的c-Src磷酸化。Syk显性负性突变体而非表皮生长因子受体阻断剂AG1478也可抑制Ang II诱导的VSMC蛋白质合成。这些数据表明,VSMC中表达的Syk在胞质磷脂酶A2和通过LO生成AA代谢产物后,被Ang II通过p38 MAPK激活的c-Src激活,并介导Ang II诱导的蛋白质合成,而与表皮生长因子受体反式激活无关(Ang II→cPLA2→LO的AA代谢产物→p38 MAPK→c-Src→Syk→蛋白质合成)。